2m 2m 2m 2m 2m 2m 2m
NEKTAR THERAPEUT (NKTR)
NASDAQ
$74.50+$0.48 (+0.65%)
Price as of Aug 21, 2026 7:32 PM EDT- $2.5BMarket Cap
- 173.84%1-Year Change
- BiotechnologyIndustry
NEKTAR THERAPEUT (NKTR)
$74.50+$0.48 (+0.65%)
NKTR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $74.02 | ||
Change | -$0.51 (-0.68%) | ||
Open | $75.10 | ||
High | $76.23 | ||
Low | $72.83 | ||
Previous Close | $74.53 | ||
Volume | 614,081 | ||
30-Day Average Volume | 642,582 | ||
1-Week Change | 1.37% | ||
1-Month Change | 7.79% | ||
1-Year Change | 173.84% | ||
3-Year Change | 593.75% | ||
5-Year Change | -63.74% | ||
Fundamentals | |||
Shares Outstanding | 34.1M | ||
Total Assets | $1.1B | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $10.1M | ||
Net Income | -$40.6M | ||
Free Cash Flow | -$75.9M | ||
EBIT | -$40.6M | ||
EBITDA | -$40.5M | ||
Net Working Capital | $668.4M | ||
EPS | -$1.23 | ||
Enterprise Value/EBITDA | -61 | ||
Enterprise Value/Revenue | 246 | ||
P/B | 3 | ||
P/E | -60 | ||
PEG | -2 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 06/09/2025 | ||
Earnings & Revenue